Breaking News

Molex Closes Acquisition of Vectura Group

Expands Phillips Medisize’s inhalation drug delivery capabilities.

Author Image

By: Charlie Sternberg

Associate Editor

Molex, a parent to Phillips Medisize, has completed, through an affiliate, the previously announced acquisition of Vectura Group Ltd. from Vectura Fertin Pharma Inc., a subsidiary of Philip Morris International Inc. With the addition of Vectura, Phillips Medisize now offers a wider range of formulation, device design, combination product development and manufacturing services. The transaction includes Vectura’s proprietary technology and combination product development expertise in dry powder...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters